Serial Number
97706107
Owner
Verséa Holdings, Inc.Attorney
George R. SchultzFirst Use Date
May 31, 2022
Filing Date
Dec 6, 2022
VERSÉA Trademark
Serial Number: 97706107
Trademark Classes
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 44 - Medical Services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Owner Contact Info
Legal Representation
Correspondence Address
George R. Schultz Schultz & Associates, P.C.
15770 N. Dallas Pkwy
Suite 475
Dallas, TX 75248
United States
Trademark Details
Filing Date
December 6, 2022
Registration Date
Not Registered
First Use Anywhere
May 31, 2022
First Use in Commerce
May 31, 2022
Published for Opposition
May 28, 2024
Goods & Services
Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; pregnancy testing preparations; ovulation test kits; diagnostic kits comprised of medical diagnostic test strips for use in disease detection, namely, urinary tract infection; vitamins and dietary supplements; natural dietary supplements; dietary and nutritional supplements; eye care, ophthalmology, and optometry products, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing, along with reader devices, sold together as a unit
Healthcare services; healthcare screenings and personalized medicine services
Medical and scientific research; pharmaceutical research; research, testing, design, and development of pharmaceuticals; research, testing, design, and development of product packaging; research, testing, design, and development of perishables packaging; research, testing, design, and development of food packaging; software as a service (SAAS) services, namely, providing a software platform that utilizes machine learning to assess and screen pharmaceutical drug candidates
